Patent · US Active

MAPK/ERK kinase inhibitors

US7943659B2 · kind B2 · utility

0Cited by
0References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2007
Grant dateMay 17, 2011
Priority date—
Expiry dateMay 23, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds, pharmaceutical compositions, kits and methods are provided for use with MEK that comprise a compound selected from the group consisting of:wherein the variables are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.